These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7993110)

  • 1. [Acquired resistance and cross-resistance of gemcitabine to cisplatin or vindesine in human lung cancer xenografted in nude mice].
    Fujita F; Fujita M; Fujita M; Sakamoto Y
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2749-55. PubMed ID: 7993110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor activity of combination treatment combining gemcitabine with cisplatin or vindesine against human lung cancer xenografted in nude mice].
    Fujita F; Fujita M; Fujita M; Sakamoto Y
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2595-601. PubMed ID: 7979419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor activity of combination treatment combining gemcitabine with topotecin against human lung cancer xenografted in nude mice].
    Fujita F; Koike M; Fujita M
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):577-84. PubMed ID: 11977542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
    Fujita F; Fujita M; Sakamoto Y; Taguchi T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):215-21. PubMed ID: 8382036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
    Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
    Furuse K; Fukuoka M; Asamoto H; Niitani H; Kimura I; Sakuma A; Yamaguchi Y
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma.
    Kawahara M; Furuse K; Kodama N; Yamamoto M; Kubota K; Takada M; Negoro S; Kusunoki Y; Matui K; Takifuji N
    Cancer; 1991 Aug; 68(4):714-9. PubMed ID: 1649683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer.
    Dooms CA; Lievens YN; Vansteenkiste JF
    Eur Respir J; 2006 May; 27(5):895-901. PubMed ID: 16481384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
    van Moorsel CJ; Pinedo HM; Veerman G; Bergman AM; Kuiper CM; Vermorken JB; van der Vijgh WJ; Peters GJ
    Br J Cancer; 1999 Jun; 80(7):981-90. PubMed ID: 10362105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine.
    Sun J; Blaskovich MA; Knowles D; Qian Y; Ohkanda J; Bailey RD; Hamilton AD; Sebti SM
    Cancer Res; 1999 Oct; 59(19):4919-26. PubMed ID: 10519405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between cisplatin and gemcitabine in vitro and in vivo.
    Peters GJ; Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Braakhuis BJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):72-9. PubMed ID: 7481849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
    Comella P; Frasci G; Panza N; Manzione L; Lorusso V; Di Rienzo G; Cioffi R; De Cataldis G; Maiorino L; Bilancia D; Nicolella G; Natale M; Carpagnano F; Pacilio C; De Lena M; Bianco A; Comella G
    J Clin Oncol; 1999 May; 17(5):1526-34. PubMed ID: 10334540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
    Shimizu E; Ogura T; Sone S; Nakayama T; Doi H; Takishita Y; Bando H; Kobayashi M; Kimura K; Sasaki H
    Oncology; 1993; 50(1):5-9. PubMed ID: 8380634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of a vindesine-resistant human small-cell lung cancer cell line.
    Ohta S; Nishio K; Kubo S; Nishio M; Ohmori T; Takahashi T; Saijo N
    Br J Cancer; 1993 Jul; 68(1):74-9. PubMed ID: 8391305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.
    Santo A; Genestreti G; Terzi A; Azzoni P; Sava T; Manno P; Molino A; Pattaro C; Micciolo R; Cetto GL
    Lung Cancer; 2006 Sep; 53(3):355-60. PubMed ID: 16837100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency and tolerance of aranose combinations with cisplatin and gemcitabine in experimental lung cancer.
    Pokrovsky VS; Lesnaya NA; Romanenko VI; Treshalina EM
    Bull Exp Biol Med; 2009 Dec; 148(6):911-4. PubMed ID: 21116505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Five-day continuous infusion of vindesine in the treatment of non-small cell lung cancer--clinical pharmacokinetics of vindesine].
    Saito Y; Mori K; Tominaga K; Yokoi K; Miyazawa N
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2129-32. PubMed ID: 1653559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.